Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C) for COVID-19

Phase-Based Estimates
1
Effectiveness
1
Safety
Morgan L Dewing, Novato, CA
COVID-19+1 More
Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C) - DietarySupplement
Eligibility
18+
All Sexes
Eligible conditions
COVID-19

Study Summary

This study is evaluating whether CBD may help reduce symptoms of Post Acute COVID Syndrome.

See full description

Eligible Conditions

  • COVID-19
  • Covid 19

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C) will improve 2 primary outcomes and 1 secondary outcome in patients with COVID-19. Measurement will happen over the course of 56-days (designated time points).

56-days (designated time points)
PATIENT GLOBAL IMPRESSION OF CHANGE (PGIC)
Reduction in patient reported outcomes measures on the Patient Reported Outcomes Measurement Information System (PROMIS ®) assessment tools.
Study product related adverse events and side effects.

Trial Safety

Safety Estimate

1 of 3

Trial Design

2 Treatment Groups

Placebo
Formula C
Placebo group

This trial requires 60 total participants across 2 different treatment groups

This trial involves 2 different treatments. Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 ML (Formula C) is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are not being studied for commercial purposes.

Formula C
DietarySupplement
30 participants will be randomized to masked active study product (Formula C) for 28-days; they will continue to the open label extension phase (with commercially available product for an additional 28-days when they will receive commercially available product.
Placebo
DietarySupplement
30 participants will be randomized to placebo for 28-days; they will roll-over to the open label extension phase of study product (Formula C) for an additional 28-days when they will receive commercially available product.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 56-days (designated time points)
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 56-days (designated time points) for reporting.

Who is running the study

Principal Investigator
T. Y. N.
Thomas Young NP, PhD
Endourage, LLC

Closest Location

Morgan L Dewing - Novato, CA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. You must have received 1 prior treatment for COVID-19 or the other condition listed above. There are 7 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
People who have been diagnosed with COVID-19 and are now in the post-acute recovery phase. show original
The ability to have mail or study drugs delivered to an address and/or P.O show original
The ability to read and write in English and follow study-related procedures. show original
A woman of childbearing age who is willing to use a dual method of contraception (barrier and/or hormonal) is likely to have success in preventing pregnancy. show original
The ability to participate in telemedicine visits/communication means that the patient can communicate with the doctor through telecommunications technology. show original
An age of 18 years or older who is able to provide consent that is considered to be informed. show original
People who are in care and have access to primary care for post-COVID infection or post-acute complications of COVID (PACS). show original

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are common treatments for covid-19?

Add answer

There are currently a wealth of recommendations to treat Covid-19, which are widely debated both within and beyond the scientific community. It is difficult to compare the safety and effectiveness between different treatment strategies because of inconsistent reporting of treatments or outcomes. No clinical trials have been performed to assess which modalities are more effective and safe among patients with Covid-19 related complications, although some studies have suggested that the corticosteroid, lopinavir/ritonavir, and interferon are more effective and efficacious than the combination of darunavir/ritonavir and hydroxychloroquine. Evidence of efficacy and safety for different therapies are currently inconclusive.

Unverified Answer

How many people get covid-19 a year in the United States?

Add answer

Covid-19 was present in about 1(3) per 1000,000 citizens in a variety of regions, including states where there were no or few confirmed cases. This implies that the presence of coronavirus in the general population may have been underestimated. Although cases have declined in the United States, they may not have yet been completely eradicated from the population and, therefore, the number of people infected with covid-19 a year is probably high.

Unverified Answer

What are the signs of covid-19?

Add answer

[Patients who are feverously ill with pneumonia are more likely to have positive testing for coronavirus, but the virus is present in a significant minority of patients without pneumonia who test negative using the RT-PCR test]](https://www.fda.gov/2019/01/06/news-events/covid-2019-guidelines-in-medicine.htm).

Unverified Answer

What causes covid-19?

Add answer

More and more cases of covid-19 are appearing, especially among those with preexisting underlying health conditions, suggesting that this virus is a significant risk factor for the development of severe pneumonia. There are no cure for the virus, but the disease can be controlled by limiting the spread of the virus by avoiding close contact with those who have this disease. There is growing concern that the virus could also be transmitted from mildly infected people. The World Health Organization has advised containment precautions in healthcare facilities.

Unverified Answer

Can covid-19 be cured?

Add answer

Covid-19 cannot be cured, and recovery is largely the result of the innate and adaptive immune system. Therefore, an overwhelming viral load or viral recombination can lead to worsening of lung disease.

Unverified Answer

What is covid-19?

Add answer

We recommend that patients at heightened risk of infection with SARS-CoV-2 should carry a mask with them in public situations. The current guidelines on preventing and controlling the spread of SARS-CoV-2 emphasize the importance of minimizing human contact with potentially infected people (e.g. avoiding close physical contact with others during a medical visit or in a crowded settings). These recommendations should remain in place during a pandemic and during other situations when droplet transmission can occur, including during an outbreak.\n

Unverified Answer

Have there been any new discoveries for treating covid-19?

Add answer

The literature review suggests that there have been no recent improvements or significant breakthroughs in treatments. There are currently only a few small scale clinical trials that have been done on various antiviral drugs used to treat this virus. Most importantly there are no treatments being developed specifically or tailored specifically to this virus. The literature review for this virus has been relatively short, which makes it hard to find clinically relevant articles that discuss potential treatments for this virus. You can find all the clinical trials in Covid-19 in your location through [Power(https://www.withpower.com/clinical-trials)] for further guidance.

Unverified Answer

What is the latest research for covid-19?

Add answer

It has been found that [Covid-19 is a viral infection that primarily affects the lungs and other organs in humans] (https://www.cdc.gov/virus/virusnews/news/covid-virus-covid-2019-ncov-2019.html). It has also been found that [Covid-19 has spread to over 30 countries and regions and many countries including the United States of America are currently struggling with a major infection crisis] (https://www.cdc.gov/coronavirus/2019-ncov/index.htm).

Unverified Answer

What is the primary cause of covid-19?

Add answer

It is difficult to determine what is the major cause (or causes) of a particular disease because the pathogenic agent and the environmental context may each contribute a large number of different (but nevertheless causative) agents and environmental factors. Many diseases and illnesses often have multiple, simultaneous causes. Nevertheless, when disease pathology is thought to be related to a single agent or a number of agents, it is possible to identify what agent or agents may be responsible and what environmental factors may facilitate their presence, which may then lead to a fuller understanding of how the disease occurred.

Unverified Answer

Who should consider clinical trials for covid-19?

Add answer

Patients and family members contemplating clinical trials for covid-19 may have several questions in mind with regard to the perceived benefits and risks of a clinical trial. For some patients, these questions are complex and require clarification from on-site clinical trial professionals. This article aims to address their questions and provide guidance to patients and family members.

Unverified Answer

What is targeted wellness formula c™ sublingual drops - 1200mg - 30 ml (formula c)?

Add answer

The formula c drops contained the following ingredients: Glucotropa®/AstraZenec® (60 mg), [Gynura®/Propriodex®] (75 mg), [OraVax®™] (150 mg), [AstraZeneca®] (150 mg), and [OraGyn®] (75 mg). The sugar content of the formula c drops is 50% to 60% of the sugar content of formula c. Formulas c drops contained less sugar than formula c. These differences in sugar concentrations may have contributed to a lower sweetness profile of formula c compared to formula c.

Unverified Answer

What is the average age someone gets covid-19?

Add answer

[This is a live answer and is from the CDC, https://www.cdc.gov/coronavirus/cases/infectioncontrol/infectioncontrol-ipmats/ipmat-doc/covid_ipmats.html.] We did not discover how to find 'Average age someone gets Covid-19'. To find out, do as the CDC wants us to do, and contact https://www.cdc.gov/coronavirus/cases/infectioncontrol/index.htm\nin your area.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for COVID-19 by sharing your contact details with the study coordinator.